Compare KOD & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOD | IHS |
|---|---|---|
| Founded | 2009 | 2001 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2018 | 2021 |
| Metric | KOD | IHS |
|---|---|---|
| Price | $38.89 | $8.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $35.43 | $8.29 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.36 |
| Revenue Next Year | N/A | $6.90 |
| P/E Ratio | ★ N/A | $5.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $4.21 |
| 52 Week High | $45.60 | $8.95 |
| Indicator | KOD | IHS |
|---|---|---|
| Relative Strength Index (RSI) | 64.44 | 60.79 |
| Support Level | $21.82 | $7.82 |
| Resistance Level | $45.60 | $8.34 |
| Average True Range (ATR) | 3.61 | 0.09 |
| MACD | 1.72 | 0.00 |
| Stochastic Oscillator | 73.03 | 86.04 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.